Results of the national lung cancer screening trial: where are we now?
- PMID: 25901558
- PMCID: PMC4817217
- DOI: 10.1016/j.thorsurg.2014.11.002
Results of the national lung cancer screening trial: where are we now?
Erratum in
-
Erratum.Thorac Surg Clin. 2020 May;30(2):xi. doi: 10.1016/j.thorsurg.2020.02.002. Thorac Surg Clin. 2020. PMID: 32327182 No abstract available.
Abstract
The National Lung Screening Trial was a large, multicenter, randomized controlled trial published in 2011. It found that annual screening with low-dose CT (LDCT) in a high-risk population was associated with a 20% reduction in lung cancer-specific mortality compared with conventional chest radiography. Several leading professional organizations have since put forth lung cancer screening guidelines that include the use of LDCT, largely on the basis of this study. Broad adoption of these screening recommendations, however, remains a challenge.
Keywords: Low-dose CT; Lung cancer; NLST; Screening.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest/disclosure statement:
All authors declare no conflicts of interest and have no disclosures to make.
Figures
References
-
- Wender RC, Smith R, Harper D. Cancer screening. Primary care. 2002 Sep;29(3):697–725. - PubMed
-
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014 Jan-Feb;64(1):9–29. - PubMed
-
- Moyer VA. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2012;157(2):120–134. - PubMed
-
- DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA: a cancer journal for clinicians. 2014 Jul;64(4):252–271. - PubMed
-
- Weinberg DS, Schoen RE. Screening for colorectal cancer. Ann Intern Med. 2014 May 6;160(9) - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
